Leef Brands (LEEEF) Cash from Financing Activities (2025 - 2026)

Leef Brands (LEEEF) reported Cash from Financing Activities of $3.7 million for Q1 2026, up 1914.86% on a YoY basis from $181903.0 in Q1 2025, and up 1914.86% sequentially from $181903.0 in Q1 2025.

Leef Brands (LEEEF) Cash from Financing Activities (2025 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 2 years of Cash from Financing Activities data on file, last reported at $3.7 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 3.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.67 Mn
Mar 31, 2026 3.67 Mn
Mar 31, 2025 181,903.00
Mar 31, 2025 181,903.00